Julie Menard

Summary

Country: Canada

Publications

  1. ncbi Oral hypoglycemic agents for gestational diabetes mellitus?
    Ana Cristina Maymone
    Division of Endocrinology, Department of Medicine, Centre Hospitalier Universitaire de Sherbrooke, 3001, 12th Avenue North, Sherbrooke Quebec J1H 5N4, Canada
    Expert Opin Drug Saf 10:227-38. 2011
  2. ncbi Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial
    Julie Menard
    Diabetes and Metabolism Research Group, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
    CMAJ 173:1457-66. 2005
  3. ncbi Comparison of foot-to-foot and hand-to-foot bioelectrical impedance methods in a population with a wide range of body mass indices
    Claudia Gagnon
    Department of Medicine, Division of Endocrinology, Centre de Recherche Clinique Etienne Le Bel, Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke, Canada
    Metab Syndr Relat Disord 8:437-41. 2010
  4. ncbi Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study
    Maude Gagnon-Auger
    Department of Medicine, Division of Endocrinology, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
    Diabetes Care 33:2502-7. 2010
  5. ncbi Dietitian-coached management in combination with annual endocrinologist follow up improves global metabolic and cardiovascular health in diabetic participants after 24 months
    Marie Claude Battista
    Department of Medicine, Universite de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada
    Appl Physiol Nutr Metab 37:610-20. 2012

Collaborators

Detail Information

Publications5

  1. ncbi Oral hypoglycemic agents for gestational diabetes mellitus?
    Ana Cristina Maymone
    Division of Endocrinology, Department of Medicine, Centre Hospitalier Universitaire de Sherbrooke, 3001, 12th Avenue North, Sherbrooke Quebec J1H 5N4, Canada
    Expert Opin Drug Saf 10:227-38. 2011
    ..Oral treatment as a more user-friendly alternative may thus facilitate the control of GDM in some patients...
  2. ncbi Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial
    Julie Menard
    Diabetes and Metabolism Research Group, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
    CMAJ 173:1457-66. 2005
    ..We sought to determine whether a 1-year intensive multitherapy program resulted in greater goal attainment than usual care among patients with poorly controlled type 2 diabetes mellitus...
  3. ncbi Comparison of foot-to-foot and hand-to-foot bioelectrical impedance methods in a population with a wide range of body mass indices
    Claudia Gagnon
    Department of Medicine, Division of Endocrinology, Centre de Recherche Clinique Etienne Le Bel, Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke, Canada
    Metab Syndr Relat Disord 8:437-41. 2010
    ..We aimed to compare multifrequency hand-to-foot (HF-BIA) and foot-to-foot (FF-BIA) bioelectrical impedance analysis techniques to assess fat-free mass (FFM) in a population with a wide range of body mass indices (BMI)...
  4. ncbi Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study
    Maude Gagnon-Auger
    Department of Medicine, Division of Endocrinology, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
    Diabetes Care 33:2502-7. 2010
    ..In obese patients, however, daily dosages are larger and ATBF is decreased. This study assessed the kinetics of a short-acting insulin analog in obese subjects with type 2 diabetes...
  5. ncbi Dietitian-coached management in combination with annual endocrinologist follow up improves global metabolic and cardiovascular health in diabetic participants after 24 months
    Marie Claude Battista
    Department of Medicine, Universite de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada
    Appl Physiol Nutr Metab 37:610-20. 2012
    ....